RegeneRx Biopharmaceuticals, Inc. RGNXW Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
RegeneRx Biopharmaceuticals, Inc. RGNXW Company Overview 

Stock Message Board http://investorshangout.com/search?q=RGNXW&am...mp;yt1=Go!

RegeneRx Biopharmaceuticals, Inc. RGNXW Current Price and Quotes
0.01
Previous Close
0.01
Open
N/A

Daily Range
N/A - N/A
52wk Range
0.275 - 0.0002

Volume
0
Dividend
N/A

Average Vol (3m)
6,395
Yield
N/A

RegeneRx Biopharmaceuticals, Inc. RGNXW
Company Information
15245 Shady Grove Road
Suite 470
Rockville, MD 20850

Website: http://www.regenerx.com/wt/home/index
Phone: 301-208 9191
Email: info@regenerx.com

RegeneRx Biopharmaceuticals, Inc. RGNXW
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.

RegeneRx Biopharmaceuticals, Inc. RGNXW
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000707511
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1995
Employees Not Available
Company Officers/Contacts
J.J. Finkelstein President, CEO
C. Neil Lyons CFO
Albert Rosenfeld Secretary
Company Directors
Not Available
Company Notes
Formerly=Alpha 1 Biomedicals, Inc. until 12-00
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

RegeneRx Biopharmaceuticals, Inc. RGNXW
RGNXW Security Details Other Company Securities
Share Structure
Market Value1 $115,000 a/o Aug 30, 2013
Shares Outstanding 11,500,000 a/o May 17, 2010
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record 4,400 a/o Mar 31, 2010
Short Selling Data
Short Interest 0 (-100%)
Sep 30, 2011
Significant Failures to Deliver  No
Transfer Agent(s)


RegeneRx Biopharmaceuticals, Inc. RGNXW Recent News


Jun 24, 2013 RegeneRx Releases Results of Phase 2 Clinical Trial on Patients with Epidermolysis Bullosa


RegeneRx Biopharmaceuticals, Inc. RGNXW Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 1,343 1,512 850 -
Cost of Revenue - - - -
Gross Profit 1,343 1,512 850 -
Operating Expenses
Research and Development 1,162 5,067 2,708 3,725
Sales, General and Admin. 1,022 2,456 3,174 2,782
Non-Recurring Items - - - -
Other - - - -
Operating Income (841) (6,012) (5,032) (6,506)
Income From Continuing Operations
Add'l Income/Expense Items - 4 8 12
Earnings Before Interest and Tax (841) (6,007) (5,024) (6,494)
Interest Expense 6 - - -
Earnings Before Tax (847) (6,007) (5,024) (6,494)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (847) (6,007) (5,024) (6,494)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (847) (6,007) (5,024) (6,494)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (847) (6,007) (5,024) (6,494)

RGNXW RegeneRx Biopharmaceuticals, Inc. Research DD Guide

RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=RGNXW&am...mp;yt0=Go!
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/RGNXW/quote
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/RGNXW/chart
RGNXW RegeneRx Biopharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/RGNXW/company-info
RGNXW RegeneRx Biopharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/RGNXW/news
RGNXW RegeneRx Biopharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/RGNXW/financials
RGNXW RegeneRx Biopharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/RGNXW/filings
RGNXW RegeneRx Biopharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/RGNXW/short-sales
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/RGNXW/insider-transactions
RGNXW RegeneRx Biopharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/RGNXW/research
RGNXW RegeneRx Biopharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=RGNXW+Historical+Prices
RGNXW RegeneRx Biopharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=RGNXW+Basic+Chart
RGNXW RegeneRx Biopharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=RGNXW+Basic+Tech.+Analysis
RGNXW RegeneRx Biopharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=RGNXW+Headlines
RGNXW RegeneRx Biopharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=RGNXW+Press+Releases
RGNXW RegeneRx Biopharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=RGNXW+Profile
RGNXW RegeneRx Biopharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=RGNXW+Key+Statistics
RGNXW RegeneRx Biopharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=RGNXW+Industry
RGNXW RegeneRx Biopharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=RGNXW+Major+Holders
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=RGNXW+Insider+Transactions
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=RGNXW+Insider+Roster
RGNXW RegeneRx Biopharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=RGNXW+Cash+Flow&annual
RGNXW RegeneRx Biopharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/RGNXW:US
RGNXW RegeneRx Biopharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/RGNXW/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 3

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading
HackerOne Finds Cybersecurity Challenges in Exposure Debt

Updated Category News Views 14

Understanding the Implications of 'Exposure Debt' When you hear about 'exposure debt', it's not just tech jargon—it's a core issue hacking at the very safety nets companies rely on. This term, highlighted in HackerOne's latest Security Research Report, marks a stark reality in cybersecurity. The backlog of verified yet unresolved vulnerabilities surged a whopping 131%...

Continue Reading
TKO's Bold $2B All-Cash Move for SVC's Hotels

Updated Category News Views 5

TKO's Big, Bold Bid: What Does it Mean? In the crazy world of high-stakes hospitality investments, there are moments that turn heads. TKO's $2 billion all-cash offer to snag Service Properties Trust's prized hotel portfolio is exactly one of those shake-ups. Let's not sugarcoat it; this is a bold move to the big leagues, and it's not without its quirks. A Cash-Infused...

Continue Reading
Korea Tourism’s Quiz Offers Free Trip Sweepstakes

Updated Category News Views 4

A Shot at Adventure Without Opening Your Wallet Let me tell you, Korea's got a way of sweeping folks off their feet with a little something for everyone—from a foodie’s paradise to history buff heaven. The Korea Tourism Organization's (KTO) New York Office is lighting up the stage with a slick offer: enter a quiz on their website and you might just be jetting off to...

Continue Reading
Navigating Career Growth Beyond Job Titles at Webinar

Updated Category News Views 5

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Continue Reading
2026 Leica Oskar Barnack Awards Spotlight Global Talent

Updated Category News Views 7

Winners Redefine Photography's Boundaries in 2026 Photographers are like modern-day storytellers, freezing moments in time and weaving visual narratives that provoke thought—or at least that's what the folks behind the Leica Oskar Barnack Award (LOBA) seem to believe. This year's ceremony upped the ante, not just handing out glittering prizes and shiny cameras, but...

Continue Reading
Morphe’s Auction Hits High Notes with Fine Jewelry

Updated Category News Views 6

Luxurious Gems Steal the Spotlight When the gavel dropped at Morphy's Fine Jewelry & Watches Auction, it set the stage for a spectacular showcase of opulent treasures. The event, highlighting 632 lots and tallying over $1.8 million in sales, left bidders buzzing in anticipation of their next chance to snag a slice of elegance. Bvlgari's Serpentine Charm In the spotlight...

Continue Reading
Chianti Classico Showcases 2027 Vintages in Florence

Updated Category News Views 4

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...

Continue Reading
STRATA Showcases Excimer Laser Success in Dermatology

Updated Category News Views 4

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Continue Reading
Poker Fans Flock to Venom PKOs and WSOP Paradise

Updated Category News Views 5

October's High Stakes Poker Action The poker buzz right now is centered around Americas Cardroom. With $5.5 million in guarantees across two major tournaments – the No-Limit Hold'em and Pot-Limit Omaha – players are reaching for their cash, hoping to lock in big wins. Day 1B kicks off today, offering a dynamic mix of players vying for their shot at glory while taking...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth Trends in Indolent Lymphoma Therapy Market Explained

Updated Category News Views 163

Understanding the Indolent Lymphoma Market Growth The indolent lymphoma market is currently experiencing significant growth, driven primarily by the rising incidence of slow-growing non-Hodgkin lymphomas and increased awareness regarding early diagnosis. Notably, the introduction of innovative therapies has played a substantial role in this expansion. Emerging treatments...

Continue Reading
Families Seek Quality Schools: What to Consider This Season

Updated Category News Views 112

Families Choosing Top-School Districts for Relocation As families prepare to relocate, many are prioritizing school districts known for their exceptional educational offerings. This trend is evident as households focus on neighborhoods with reputable schools, enhancing both their living standards and their children's learning opportunities. The latest analysis has...

Continue Reading
Empowering Women: Highlights from the Abuser's Playbook Workshop

Updated Category News Views 119

Empowering Women Through Knowledge and Advocacy Recently, authors Amy Polacko and Dr. Christine M. Cocchiola, known for their powerful book, Framed: Women in the Family Court Underworld, organized a significant workshop with the support of Mommy's Heart. Held at a venue in New York City, this workshop addressed the challenges women face in family court settings,...

Continue Reading
Zealand Pharma Wrapping Up ZUPREME-1 Trial Enrollment Success

Updated Category News Views 231

Zealand Pharma Successfully Completes Enrollment in ZUPREME-1 Trial Zealand Pharma A/S (NASDAQ: ZEAL), a biotechnology company dedicated to innovating peptide-based medicines, has proudly announced the completion of participant enrollment in the Phase 2b ZUPREME-1 clinical trial. This exciting milestone comes shortly after the trial's inception, marking significant...

Continue Reading
Protective Clothing Sector Projected to Hit $18.6 Billion by 2033

Updated Category News Views 106

Projected Growth of the Protective Clothing Market The protective clothing market is on an exciting upward trajectory, expected to reach an impressive valuation of $18.6 billion within the next decade. This anticipated growth, at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2033, reflects the increasing awareness towards workplace safety and the growing need...

Continue Reading